MAPK3 and colitis: Since TGF-β1 inhibits IEC proliferation and promotes differentiation [36–38], downregulation of this peptide during the acute phase of colitis can facilitate the mitogenic effects of ERK1/2, whereas TGF-β1 upregulation in the recovery phase can enhance differentiation.